Compare Gigacloud Technology Inc (GCT) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs Medpace Holdings Inc — how do they compare? Gigacloud Technology Inc trades at $57.26 (market cap $2.02B), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: Medpace Holdings Inc is far larger — about 8.3× Gigacloud Technology Inc's market cap, and Medpace Holdings Inc is more actively traded (223,093 versus 1,020,985). Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 21 Days and Medpace Holdings Inc for 14 Days on average.
| GCT | MEDP | |
|---|---|---|
Market Cap | $2.02B | $16.82B |
Volume | 1,020,985 | 223,093 |
Sector | Technology | Health |
52-Week High | $57.26 | $630.19 |
52-Week Low | $25.46 | $393.42 |
Typical Hold Time | 21 Days | 14 Days |
Enterprise Value | $2.14B | $16.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $56.42, up 0.82% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 10.65% net margins and consistent earnings beats, though the current price exceeds analyst consensus targets. Recent news highlights institutional interest and European expansion potential.
GCT offers growth potential through international expansion and strong execution but faces risks from insider selling and valuation concerns. The stock trades above most analyst targets, suggesting limited near-term upside despite solid fundamentals and positive technical indicators.
Medpace (MEDP) trades at $602.70, down slightly by 0.26% on the day, with a neutral technical outlook and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue and net income are projected to grow in 2026, supported by a robust 17.67% net income margin and exceptional ROE of 162.15%. However, valuation ratios like P/E of 35.41 and P/B of 38.77 suggest a premium pricing relative to peers.
The stock offers upside to the consensus price target of $620.44, but risks include high valuation multiples, CEO stock sales, and mixed institutional positioning. Investors should weigh strong profitability against potential overvaluation and monitor Q3 earnings for continued momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
